Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Lokivetmab reduced itching in a dog with skin lymphoma.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

miR-21 helps improve ovarian function recovery in treated mice.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Ritlecitinib can help about 14,000 people with severe hair loss.

Early use of infliximab in severe pediatric Crohn's disease can lead to significant improvement and remission.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Calancardin B may help reduce inflammation in immune cells.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Stem cell vesicles reduced eczema symptoms in mice safely.